T
Tharimmune
Digital Asset Treasury https://tharimmune.com
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
지표 추이 (최근 90일, RD 인기지수)
추이 데이터가 아직 부족합니다.
펀딩 이력
Post-IPO
리드 투자
$540,000,000
DRW Venture CapitalLiberty City VenturesKrakenPolychain
Source from
